Tylenol
Kimberly-Clark’s $48.7 Billion Kenvue Acquisition Reshapes Consumer Health Industry
Kimberly-Clark’s landmark $48.7 billion acquisition of Kenvue, the owner of Tylenol and Band-Aid, marks a seismic shift in the consumer staples sector, merging iconic brands and creating one of the industry’s largest players.
Tylenol Autism Lawsuits Ignite Fierce Debate Over Science and Policy
Allegations linking Tylenol use during pregnancy to autism have sparked heated lawsuits and political controversy, but scientific evidence remains inconclusive, leaving parents and policymakers grappling with uncertainty.
Trump’s Autism Announcement Sparks Debate Over Tylenol Use in Pregnancy
President Trump’s latest move to connect autism risk to Tylenol use during pregnancy has ignited fierce debate among medical experts, advocates, and policymakers, challenging long-held guidelines and raising fresh questions about science and public health.